Indapamide Lp Krka

Indapamide, the active ingredient in Indapamide Lp Krka, is a thiazide‑like diuretic presented as a tablet for oral use. It lowers blood pressure and reduces fluid retention in patients with hypertension, heart‑failure‑related edema, or renal‑disease‑associated edema.

GNH USA supplies Indapamide Lp Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand. Logistics are managed with temperature‑controlled shipping where required, ensuring product integrity upon delivery.

Indapamide is used to manage conditions related to elevated blood pressure and fluid overload.

Hypertension: reduces systolic and diastolic blood pressure, improving cardiovascular risk profile. Edema associated with heart failure: promotes diuresis to decrease fluid accumulation and relieve symptoms. Edema associated with renal disease: enhances urinary sodium excretion to control swelling in chronic kidney disease.

Indapamide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Dizziness - Headache - Increased urination - Electrolyte imbalance (low potassium)

Serious or Rare Side Effects: - Severe dehydration - Acute kidney injury - Severe hypotension

Before initiating therapy, clinicians should consider several safety measures.

Monitor electrolytes: regular blood tests to detect sodium and potassium changes. Assess renal function: evaluate kidney performance before and during treatment. Adjust dose in elderly: start low and monitor for orthostatic hypotension. Avoid use in severe hepatic impairment: contraindicated due to altered metabolism. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Indapamide can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Lithium: increased lithium levels leading to toxicity. - NSAIDs: reduced diuretic efficacy and possible renal impairment. - ACE inhibitors/ARBs: risk of excessive potassium rise. - Antidiabetic drugs: enhanced hypoglycemic effect.

Moderate Interactions (Monitor Closely): - Digoxin: altered serum levels. - Beta‑blockers: additive blood‑pressure lowering. - SSRIs: increased risk of hyponatremia.